Position in ROIV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,775,736
-$5,631,645 QoQ
Shares Held
64,106
-81.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Neo Ivy Capital Management holds $15,852,316 across 14 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
35,826 | $4,194,149 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
10,195 | $2,495,430 | |
| 3 | VERA |
Vera Therapeutics, Inc.
|
48,937 | $2,099,886 | |
| 4 | IMNM |
Immunome Inc.
|
80,876 | $1,713,762 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
9,798 | $1,300,488 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
14,551 | $1,291,837 | |
| 7 | TECH |
BIO-TECHNE Corp
|
11,316 | $799,475 | |
| 8 | DYN |
Dyne Therapeutics, Inc.
|
31,440 | $698,282 |
All Filings in ROIV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,775,736 | 64,106 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,407,381 | 341,354 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,591,740 | 237,392 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $811,778 | 72,030 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||